Cargando…
Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy
OBJECTIVE: The early infantile epileptic encephalopathy type 13 (EIEE13, OMIM #614558) results from de novo missense mutations of SCN8A encoding the voltage‐gated sodium channel Na(v)1.6. More than 20% of patients have recurrent mutations in residues Arg1617 or Arg1872. Our goal was to determine the...
Autores principales: | Wagnon, Jacy L., Barker, Bryan S., Hounshell, James A., Haaxma, Charlotte A., Shealy, Amy, Moss, Timothy, Parikh, Sumit, Messer, Ricka D., Patel, Manoj K., Meisler, Miriam H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748308/ https://www.ncbi.nlm.nih.gov/pubmed/26900580 http://dx.doi.org/10.1002/acn3.276 |
Ejemplares similares
-
Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015) -
Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015) -
Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse*
por: Yu, Wenxi, et al.
Publicado: (2020) -
Loss-of-function variants of SCN8A in intellectual disability without seizures
por: Wagnon, Jacy L., et al.
Publicado: (2017) -
Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020)